2001
DOI: 10.1016/s0360-3016(00)01541-8
|View full text |Cite
|
Sign up to set email alerts
|

Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
71
0
1

Year Published

2004
2004
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 136 publications
(77 citation statements)
references
References 13 publications
5
71
0
1
Order By: Relevance
“…In addition, the maximum dose to the skin and ipsilateral lung ( 7 ) was assessed. To reduce the incidence of fat necrosis ( 6 , 11 ) and dose inhomogeneity in the target, the NSABP B39/RTOG 0413 protocol limited the volume of breast tissue receiving excessive doses (V150[cc] <50 cc and V200[cc] <10 cc). ( 6 ) Hence, the V150[cc] and V200[cc] values were evaluated.…”
Section: Methodsmentioning
confidence: 99%
“…In addition, the maximum dose to the skin and ipsilateral lung ( 7 ) was assessed. To reduce the incidence of fat necrosis ( 6 , 11 ) and dose inhomogeneity in the target, the NSABP B39/RTOG 0413 protocol limited the volume of breast tissue receiving excessive doses (V150[cc] <50 cc and V200[cc] <10 cc). ( 6 ) Hence, the V150[cc] and V200[cc] values were evaluated.…”
Section: Methodsmentioning
confidence: 99%
“…While several studies have evaluated risk factors and incidence of fat necrosis with interstitial brachytherapy, reports dedicated to the evaluation of fat necrosis in BBB are limited [12,14,16,17]. To our knowledge, this is the first study dedicated to the evaluation of fat necrosis specifically in BBB.…”
Section: Purposementioning
confidence: 99%
“…A benign inflammatory process, fat necrosis is commonly caused by trauma but has also been a documented complication from radiotherapy [12][13][14][15][16]. Several studies have evaluated its incidence in brachytherapy, which ranges from 2% to 52% [2,3,5,6,9,[11][12][13][14][15][16][17][18].…”
Section: Purposementioning
confidence: 99%
“…Even when comparing relatively similar brachy-therapy techniques for delivering APBI, there remains uncertainty regarding the appropriate dosimetric criteria needed to minimize the risk of toxicities such as fat necrosis. In the initial clinical experiences with interstitial catheter-based brachy-therapy, symptomatic fat necrosis reported range from 2% to 21% of cases [81,82] .The current guidelines in the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-39/RTOG 0413 protocol regarding the volume of higher doses of radiation permissible on study are based on earlier dosimetric analyses from Tufts University and Virginia Commonwealth University that correlated larger volumes of high doses of radiation in the breast with the development of fat necrosis [83]. It is difficult to know how to translate these dosimetric constraints from one brachytherapy modality to another, which is important given that balloon and single-entry catheter based brachytherapy catheters yield significantly different dose distributions.…”
Section: Comparison Of Apbi Modalities:-mentioning
confidence: 99%